Starkstein Sergio E
Department of Psychiatry and Clinical Neurosciences, University of Western Australia and Fremantle Hospital, Western Australia, Australia.
Cortex. 2014 Dec;61:64-73. doi: 10.1016/j.cortex.2014.07.019.
Anosognosia is present in a large proportion of patients with mild Alzheimer's disease (AD), and its frequency increases with the progression of the illness. Several instruments have been validated to assess anosognosia in AD, but there is no consensus regarding the best diagnostic strategy. Anosognosia in AD is a significant predictor of apathy and is significantly related to lower depression and anxiety scores, more severe caregiver burden and dangerous behaviours. Studies using different imaging modalities have demonstrated an association between anosognosia and dysfunction in frontal, temporomedial and temporoparietal regions. The mechanism of anosognosia remains unknown, but it has been explained as a consequence of deficits of encoding and updating biographical memory, and dysfunction of comparator, executive and metacognitive systems.
很大比例的轻度阿尔茨海默病(AD)患者存在疾病感缺失,且其发生率随病情进展而增加。已有多种工具被验证可用于评估AD患者的疾病感缺失,但对于最佳诊断策略尚无共识。AD患者的疾病感缺失是冷漠的重要预测指标,且与较低的抑郁和焦虑评分、更严重的照料者负担及危险行为显著相关。使用不同成像方式的研究已证明疾病感缺失与额叶、颞内侧和颞顶叶区域功能障碍之间存在关联。疾病感缺失的机制尚不清楚,但已被解释为自传体记忆编码和更新缺陷以及比较器、执行和元认知系统功能障碍的结果。